SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
transgenics
An SI Board Since June 2000
Posts SubjectMarks Bans
41 3 0
Emcee:  Jongmans Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
41Survey on FDA Advisory Panel for ATryn: siliconinvestor.com ATryn is bidding tDewDiligence_on_SI-1/5/2009
40Biolex Acquires Full Worldwide Rights to Locteron: siliconinvestor.comDewDiligence_on_SI-10/6/2008
39Pharming Names New CEO: siliconinvestor.comDewDiligence_on_SI-9/26/2008
38Salon.com muses on transgenics (with predictable results): siliconinvestor.comDewDiligence_on_SI-6/11/2008
37<b>Immunity for beakfast?</b> By Ishani Ganguli the-scientist.com idos-3/10/2008
36Biolex, Merck KGaA to Collaborate on Antibody Optimization: siliconinvestor.comDewDiligence_on_SI-2/19/2008
35Pharming Requests EMEA Appeal on Rhucin: siliconinvestor.comDewDiligence_on_SI-1/29/2008
34Pharming gets thumbs down from EMEA on Rhucin: siliconinvestor.comDewDiligence_on_SI-12/13/2007
33Locteron update: tinyurl.comDewDiligence_on_SI-10/12/2007
32Origen update for those interested in polyclonal antibodies and/or transgenic chDewDiligence_on_SI-10/3/2007
31Invitation to prospective discussants who may wish to continue the thread… siliDewDiligence_on_SI-9/20/2007
30Thu Sep 20 12:54:10 2007 (University of Pennsylvania) <b>Penn Veterinary idos-9/20/2007
29Biolex Reports Phase-2a Results of Locteron in HCV: tinyurl.com The data look pDewDiligence_on_SI-7/26/2007
28SemBioSys Achieves Apo AI Milestone: investorshub.com Also see the Apo A1 quizDewDiligence_on_SI-7/12/2007
27GTCB’s role in Follow-On Biologics: investorshub.comDewDiligence_on_SI-7/5/2007
26No more transgenic chickens from VRA: investorshub.comDewDiligence_on_SI-6/21/2007
25Roche Acquires Therapeutic Human Polyclonals Inc. for $56.5M: investorshub.comDewDiligence_on_SI-4/2/2007
24VRA effectively filed for bankruptcy today: investorshub.comDewDiligence_on_SI-3/20/2007
23Biolex news: investorshub.comDewDiligence_on_SI-3/1/2007
22SemBioSys' plant-produced insulin chemically and physiologically equivalent DewDiligence_on_SI-1/10/2007
21FRAMINGHAM, Mass., Sept. 6 /PRNewswire-FirstCall/ -- GTC Biotherapeutics, Inc. (nigel bates-9/6/2002
20Feb. 16 /PRNewswire/ -- Pharming Group N.V. (EASDAQ: PHAR / AEX: PHAR) announcesnigel bates-2/16/2001
19Feb. 12, 2001-- PlantGenix, Inc., a Pennsylvania-based biotechnology company, tonigel bates-2/12/2001
18Dec. 11 /PRNewswire/ -- Viragen, Inc. (Amex: VRA - news) and The Roslin Institutnigel bates-12/11/2000
17PITTSBORO, N.C.--(BW HealthWire)--Dec. 5, 2000--Biolex, Inc. announced today thenigel bates-12/5/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News